Basic Biology and Detection of Cell-Free DNA




This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test. Continuing education credit is available for the webinar.


This interactive webinar is part 1 of the 8 part Utility of Cell-Free DNA in the Clinic Series.

Description:

In the rapidly evolving field of liquid biopsies, this first seminar will provide an overview of the current understanding of the biology of cell-free DNA and circulating tumor DNA in the context of healthy and benign conditions, and malignancy. Particular attention will be given to pre-analytical variables that affect the reliability of cell-free DNA assays and the clinical implications of these results.

Learning Objectives:
  • Describe typical cell sources, fragmentation, and quantities of cfDNA.
  • Recognize unique cfDNA analytes associated with specific conditions and diseases.
  • Summarize pre-analytical variables that affect recovery and detection of cfDNA.




Speaker:
Rena Xian, MD
Speaker:
Lynette M. Sholl, MD
Moderator :
Margaret Gulley, MD

Recording Date: May 18, 2021
Duration: 1 hr
Level of Instruction: Basic
CME/CMLE credit: 1.00 hour

Last Day to Claim Credit: December 31, 2023


Continuing Education Credit Information

Physicians (ACCME)           


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live to enduring activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM (1.00 CE for each webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Medical Laboratory Education (CMLE)

This activity has been planned and implemented in accordance with the Amedco and joint provider-ship of the ASC and the Association for Molecular Pathology (AMP). Course number 7013.



Supported by an educational grant from AstraZeneca   


Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation